
SolverGen
Web-based no-code platform democratizing machine learning for biomedical research with clinical-grade data security.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
N/A | Early VC | ||
Total Funding | 000k |
Related Content
SolverGen operates in the biomedical research sector, focusing on precision medicine by providing a web-based, no-code automated machine learning platform. This platform is designed to simplify the process of analyzing biomedical data, enabling researchers to produce insights, develop biomarkers, and create new drugs and therapies. SolverGen serves biomedical scientists and research institutions, aiming to empower them with advanced tools to accelerate medical research. The company generates revenue through subscription-based access to its platform, offering various tiers of service depending on the needs of the client. SolverGen's market includes academic institutions, pharmaceutical companies, and healthcare organizations that require robust data analysis capabilities. The business model is centered around providing a superior user interface and user experience with minimal ramp-up time, ensuring that clients can quickly and effectively utilize the platform. Additionally, SolverGen places a strong emphasis on data security, adhering to clinical-grade standards to protect sensitive information.
Keywords: precision medicine, machine learning, biomedical research, no-code platform, data security, biomarkers, drug development, web-based, subscription model, healthcare innovation.